Literature DB >> 19184540

The emerging field of osteoimmunology.

Kofi A Mensah1, Jie Li, Edward M Schwarz.   

Abstract

Recent studies have elucidated unanticipated connections between the immune and skeletal systems, and this relationship has led to the development of a new field known as osteoimmunology. The goal of research in this field is to: (1) further understand how the bone microenvironment influences immune cell ontogeny and subsequent effector functions, and (2) translate basic science findings in bone biology to clinical applications for autoimmune diseases that target the skeleton such as rheumatoid arthritis (RA). In this review, we will examine the recent findings of the interplay between the immune and skeletal systems. This discussion will focus on the cells and signaling pathways in osteoimmune interactions and how innate and adaptive immune effector cells as well as cytokines and chemokines play a role in the maintenance and dysregulation of skeletal-immune homeostasis. We will also discuss how immunomodulatory biologic drugs, which specifically target these cells and effector molecules, have transformed the treatment of autoimmune mediated inflammatory diseases (IMIDs) and metabolic bone diseases such as osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184540      PMCID: PMC2934875          DOI: 10.1007/s12026-009-8093-x

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  81 in total

1.  Autoimmune diseases. The B cell slayer.

Authors:  Robert Matthews
Journal:  Science       Date:  2007-11-23       Impact factor: 47.728

Review 2.  TH17 cells in development: an updated view of their molecular identity and genetic programming.

Authors:  Chen Dong
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

Review 3.  Monocyte subpopulations and their differentiation patterns during infection.

Authors:  Dalit Strauss-Ayali; Sean M Conrad; David M Mosser
Journal:  J Leukoc Biol       Date:  2007-05-02       Impact factor: 4.962

Review 4.  The function of interleukin 17 in the pathogenesis of rheumatoid arthritis.

Authors:  Agnieszka Paradowska; Włodzimierz Maślińiski; Agnieszka Grzybowska-Kowalczyk; Jan Łacki
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007 Sep-Oct       Impact factor: 4.291

Review 5.  The biological functions of T helper 17 cell effector cytokines in inflammation.

Authors:  Wenjun Ouyang; Jay K Kolls; Yan Zheng
Journal:  Immunity       Date:  2008-04       Impact factor: 31.745

6.  Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2.

Authors:  D van der Heijde; A Kavanaugh; D D Gladman; C Antoni; G G Krueger; C Guzzo; B Zhou; L T Dooley; K de Vlam; P Geusens; C Birbara; D Halter; A Beutler
Journal:  Arthritis Rheum       Date:  2007-08

Review 7.  Rheumatoid arthritis: beyond tumor necrosis factor-alpha antagonists, B cell depletion, and T cell blockade.

Authors:  Augustine M Manadan; Joel A Block
Journal:  Am J Ther       Date:  2008 Jan-Feb       Impact factor: 2.688

8.  The role of DC-STAMP in maintenance of immune tolerance through regulation of dendritic cell function.

Authors:  Yumi Sawatani; Takeshi Miyamoto; Shigenori Nagai; Mikako Maruya; Jun Imai; Kana Miyamoto; Nobuyuki Fujita; Ken Ninomiya; Toru Suzuki; Ryotaro Iwasaki; Yoshiaki Toyama; Masanori Shinohara; Shigeo Koyasu; Toshio Suda
Journal:  Int Immunol       Date:  2008-07-24       Impact factor: 4.823

9.  The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat.

Authors:  Nicolas Manel; Derya Unutmaz; Dan R Littman
Journal:  Nat Immunol       Date:  2008-05-04       Impact factor: 25.606

Review 10.  Clinical development of anti-RANKL therapy.

Authors:  Edward M Schwarz; Christopher T Ritchlin
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  8 in total

1.  Pasteurella multocida toxin-stimulated osteoclast differentiation is B cell dependent.

Authors:  Dagmar Hildebrand; Klaus Heeg; Katharina F Kubatzky
Journal:  Infect Immun       Date:  2010-10-18       Impact factor: 3.441

2.  Impaired ATM activation in B cells is associated with bone resorption in rheumatoid arthritis.

Authors:  Kofi A Mensah; Jeff W Chen; Jean-Nicolas Schickel; Isabelle Isnardi; Natsuko Yamakawa; Andrea Vega-Loza; Jennifer H Anolik; Richard A Gatti; Erwin W Gelfand; Ruth R Montgomery; Mark C Horowitz; Joe E Craft; Eric Meffre
Journal:  Sci Transl Med       Date:  2019-11-20       Impact factor: 17.956

Review 3.  Growth-plate cartilage in chronic renal failure.

Authors:  Cheryl P Sanchez
Journal:  Pediatr Nephrol       Date:  2009-10-09       Impact factor: 3.714

4.  Immunology at the university of Rochester.

Authors:  Edith M Lord
Journal:  Immunol Res       Date:  2009-02-25       Impact factor: 2.829

5.  Associations between fat distribution and volumetric bone mineral density in Chinese adults.

Authors:  Wei Zhang; Xiaohui Ma; Peng Xue; Yu Gao; Xuelun Wu; Jian Zhao; Yan Wang; Shiling Li
Journal:  Endocrine       Date:  2014-04-05       Impact factor: 3.633

6.  Serum C-C Motif Ligand 11/eotaxin-1 May Serve as a Candidate Biomarker for Postmenopausal Osteoporosis.

Authors:  Wen Wang; Ci-You Huang; Zhuo-Ping Wang; Shan-Shan Xu; Tie-Yong Qian; Yi-Ding Chen; Wei-Guo Wu
Journal:  J Med Biochem       Date:  2019-05-11       Impact factor: 3.402

7.  The Neutrophil to Lymphocyte Ratio on Admission and Short-Term Outcomes in Orthogeriatric Patients.

Authors:  Alexander Fisher; Wichat Srikusalanukul; Leon Fisher; Paul Smith
Journal:  Int J Med Sci       Date:  2016-07-05       Impact factor: 3.738

Review 8.  Osteoimmunology and Beyond.

Authors:  Lia Ginaldi; Massimo De Martinis
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.